Woerle Hans-Juergen

Woerle Hans-Juergen is listed in filings as Director at Seres Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 6, 2025, including 1 public disclosure. Recent filings connect the profile to Seres Therapeutics, Inc. (MCRB). The current snapshot covers public activity from Feb 6, 2025. Reported amounts are shown as $96.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.